Sareum Holdings PLC

SAR:LSE

Sareum Holdings PLC

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)0.74
  • Today's Change0.00 / 0.00%
  • Shares traded17.48m
  • 1 Year change252.38%
  • Beta0.2490
Data delayed at least 20 minutes, as of Aug 24 2016 16:26 BST.
More ▼

Key statistics

On Wednesday, Sareum Holdings PLC (SAR:LSE) closed at 0.74, -38.33% below its 52-week high of 1.20, set on Apr 05, 2016.
52-week range
Today
0.1733Jan 04 20161.20Apr 05 2016
Open0.74
High--
Low--
Bid--
Offer--
Previous close0.74
Average volume11.07m
Shares outstanding2.65bn
Free float1.64bn
P/E (TTM)--
Market cap19.57m GBP
EPS (TTM)-0.0005 GBP
Data delayed at least 20 minutes, as of Aug 24 2016 16:26 BST.
More ▼

Advisers

Broker
Hybridan LLP
Birchin Court
20 Birchin Lane 
London
EC3V 9DU
 
Nominated Adviser
Sanlam Securities UK Limited
10 King William Street
London
EC4N 7TW
 
Registrars
Capita Asset Services
The Registry
34 Beckenham Rd
Beckenham
Kent  BR3 4TU
 
Solicitors
Taylor Vinters
Merlin Place
Milton Road
Cambridge
CB4 0DP
 
Auditors
Shipleys LLP
10 Orange Street
Haymarket
London
WC2H 7DQ
 
Financial PR
The Communications Portfolio
7 Ensign House
Admirals Way
London
E14 9XQ
 

 

 

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.